FindTrial
Sign In

The effect analysis of awake pediatric extracorporeal membrane oxygenation (ECMO) support in treating acute fulminant myocarditis

The effect analysis of awake pediatric extracorporeal membrane oxygenation (ECMO) support in treating acute fulminant myocarditis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000031991
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-04-21
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute fulminant myocarditis

Interventions

Case series:Nil

Sponsors

Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. reversible cardiac and/or pulmonary failure; 2. without irreversible neurological injury; 3. without ECMO contraindications: uncontrolled bleeding, more than 10 days of mechanical ventilation; 4. the patients agree with awake ECMO support.

Exclusion criteria

Exclusion criteria: 1. irreversible cardiac and/or pulmonary failure; 2. brain death; 3. uncontroled bleeding; 4. the patients refuse to receive ECMO.

Design outcomes

Primary

MeasureTime frame
Mechanical Ventilation duration;—

Countries

China

Contacts

Public ContactXiaoyang Hong

Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital

jyhongxy@163.com+86 13311057633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026